drugset / Trial / NCT00395915

Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia

NCT00395915

Phase 4 Unknown 106 enrolled University of Verona
RandomizedParallel-groupOpen-labelTreatment

Summary

The principal clinical question to be answered by CHAT (Clozapine Haloperidol Aripiprazole Trial) is the relative efficacy and tolerability of combination treatment with clozapine plus aripiprazole compared to combination treatment with clozapine plus haloperidol in patients with an incomplete response to treatment with clozapine over an appropriate period of time.

Timeline

Start
2006-09
Primary completion
2009-03
Completion
2009-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified

Indications